Funding and development partners
The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:
- Global Asthma and Allergy Patient Platform (GAAPP)
- IMPALA
- We thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - “IMPALA” for helping to make this work possible. In relation to IMPALA (project reference 16/136/35) specifically: IMPALA was funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.
- OM Pharma
- Australia
- Asthma Australia
- Woolcock Institute of Medical Research
- France
- Aix Marseille University
- Georgia
- Center of Allergy & Immunology, Tbilisi
- Latvia
- Riga Stradins University
- New Zealand
- The Asthma and Respiratory Foundation of New Zealand
- Auckland Asthma Charitable Trust
- Boehringer Ingelheim
- University of Auckland
- AstraZeneca
- Spain
- University of Murcia
- Valencia University
- Sultanate of Oman
- The Oman Respiratory Society
- United Kingdom
- The London School of Hygiene and Tropical Medicine
- St Georges University of London
- UK Medical Research Council
Funders of GAN Phase I Centres
Individual centres involved in GAN Phase I data collection were funded by the following organisations:
- Argentina, San Francisco
- Funded by Dr Héctor Badellino
- Brazil, Uruguaiana
- Funded by Dr Marilyn Urrutia Pereira
- Cameroon, Yaounde
- Funded by Elvis Ndikum (95%) and from family, friends (5%)
- Costa Rica
- Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
- India; Bikaner, Chandigarh, Jaipur, Kolkata, Kottayam, Lucknow, Mysuru, New Delhi, Pune
- GAN Phase I was undertaken by Asthma Bhawan in India which was supported by Cipla foundation.
- Iran, Karaj
- Alborz University of medical Sciences
- Kosovo, Gjakova
- Municipality of Gjakova and the Directorate for Health and Education
- Mexico, all centres
- Astra Zeneca and COMPEDIA (Colegio Mexicano de Pediatras Especialistas en Inmunologia Clinica y Alergia) educational grants
- Mexico, Puerto Vallarta
- Centro Universitario de la Costa, Universidad de Guadalajara
- New Zealand, Auckland
- Auckland Asthma Charitable Trust
- Nicaragua. Managua
- Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
- Nigeria, Ibadan
- Funded by National Institute for Health Research (NIHR) (IMPALA, grant reference 16/136/35) using UK aid from the UK Government to support global health research
- Poland, Katowice
- Funded by the Medical University of Silesia
- South Africa, Cape Town
- Funded by the South African Medical Research Council and by the Allergy Society of South Africa for Heather Zar
- Spain, Cartagena, Bilbao, Pamplona
- Funded by Instituto de Salud Carlos III
- Spain, Cantabria
- Funded by Instituto de Investigación Sanitaria Valdecilla (IDIVAL) de Cantabria PRIMVAL 17/01 y 18/01,
- Spain, Salamanca
- Funded by Gerencia Regional de Salud de la Junta de Castilla y León Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica,
- Spain, A Coruña
- Funded by María José Jove foundation.
- Sri Lanka; Anuradhapura, Peradeniya
- University of Peradeniya, Peradeniya, Sri Lanka
- Syria; Damascus, Lattakia
- Damascus: Syrian Private University
- Lattakia: Lattakia Medical National Syndicate
Donations to the Global Asthma Network can be made via The University of Auckland donation page.
